A Senate committee on Thursday advanced the nomination of Dr. Erica Schwartz to serve as director of the Centers for Disease Control and Prevention (CDC), despite concerns over potential political influence, according to a report from the Associated Press. The vote marked a key step in confirming Trump’s nominee for the nation’s top public health agency. The Senate Committee on Health, Education, Labor and Pensions (HELP) voted 12-10 to move forward with Schwartz’s nomination, which had faced scrutiny over her willingness to resist political interference, the report said.
Meanwhile, the nomination of Acting Attorney General Todd Blanche remained in limbo as a group of Senate Republicans refused to support him until a controversial $1.8 billion “weaponization” fund — linked to Trump’s legal battles — is permanently dismantled, reported the New York Post. The fund, created as part of Trump’s lawsuit against the IRS, has become a point of contention among lawmakers.
Some senators, including those who have faced backlash from Trump, have expressed willingness to vote against Blanche’s nomination unless the fund is addressed. One senator, who was previously criticized by Trump, stated he is “prepared to vote no” unless the administration takes action to eliminate the fund.
The political tensions surrounding Trump’s nominees continue to shape the Senate’s legislative agenda, with key appointments hanging in the balance as lawmakers navigate complex political and ethical considerations.
